Royal Bank of Canada’s InspireMD NSPR Stock Holding History

Royal Bank of Canada’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	247 +67	+37%	+$71	﹤0.01%	7651
2026 Q1	$0	Hold	180	–	–	﹤0.01%	7497
2025 Q4	$0	Buy	+180	New	+$375	﹤0.01%	7471
2025 Q3	–	Sell	-1,167	Closed	-$3K	–	7379
2025 Q2	$3K	Hold	1,167	–	–	﹤0.01%	6749
2025 Q1	$3K	Hold	1,167	–	–	﹤0.01%	6510
2024 Q4	$3K	Hold	1,167	–	–	﹤0.01%	6656
2024 Q3	$3K	Hold	1,167	–	–	﹤0.01%	6608
2024 Q2	$3K	Hold	1,167	–	–	﹤0.01%	6664
2024 Q1	$3K	Hold	1,167	–	–	﹤0.01%	6606
2023 Q4	$3K	Hold	1,167	–	–	﹤0.01%	6739
2023 Q3	$4K	Hold	1,167	–	–	﹤0.01%	6672
2023 Q2	$3K	Hold	1,167	–	–	﹤0.01%	6796
2023 Q1	$1K	Hold	1,167	–	–	﹤0.01%	6912
2022 Q4	$1K	Hold	1,167	–	–	﹤0.01%	7057
2022 Q3	$2K	Hold	1,167	–	–	﹤0.01%	7044
2022 Q2	$2K	Hold	1,167	–	–	﹤0.01%	6977
2022 Q1	$4K	Hold	1,167	–	–	﹤0.01%	7329
2021 Q4	$4K	Hold	1,167	–	–	﹤0.01%	7279
2021 Q3	$5K	Hold	1,167	–	–	﹤0.01%	7135
2021 Q2	$6K	Hold	1,167	–	–	﹤0.01%	7029
2021 Q1	$12K	Sell	1,167 -666	-36%	-$7.93K	﹤0.01%	6719
2020 Q4	$9K	Hold	1,833	–	–	﹤0.01%	6431
2020 Q3	$9K	Buy	1,833 +666	+57%	+$4.22K	﹤0.01%	5957
2020 Q2	$8K	Hold	1,167	–	–	﹤0.01%	5915
2020 Q1	$11K	Hold	1,167	–	–	﹤0.01%	5797
2019 Q4	$19K	Buy	+1,167	New	+$18.5K	﹤0.01%	5873

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Royal Bank of Canada's NSPR Position: Q2 2026 in Review

Royal Bank of Canada increased its InspireMD (NSPR) stake by 37% in Q2 2026, buying an estimated $71 and bringing the position to 247 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7651.

Royal Bank of Canada first reported a position in NSPR in Q4 2019 and has held it in 26 quarters since. The position peaked at $19K in Q4 2019. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

Royal Bank of Canada held 247 shares of InspireMD worth $0 as of Q2 2026.
Royal Bank of Canada bought 67 InspireMD shares in Q2 2026, an estimated $71.
InspireMD made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7651 holding.
Royal Bank of Canada first reported a position in InspireMD in Q4 2019 and has held it in 26 quarters since.
Royal Bank of Canada's InspireMD position peaked at $19K in Q4 2019.
37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.